Evidence map›Paper›PMID 30208620›Full record

ArticleInternational journal of molecular sciences2018

Cellular Sources and Regional Variations in the Expression of the Neuroinflammatory Marker Translocator Protein (TSPO) in the Normal Brain.

Calina Betlazar, Meredith Harrison-Brown, Ryan J Middleton, Richard Banati, Guo-Jun Liu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Characteristics of TSPO expression in marmoset EAE.Journal of neuroinflammation · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. A dual tracer [Bioelectronic medicine · 2022
    Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Calina BetlazarAustralian Nuclear Science and Technology Organisation, New Illawarra Road, Lucas Heights, NSW 2234, Australia. calinab@ansto.gov.au.ORCID 0000-0002-5070-0959
Meredith Harrison-BrownAustralian Nuclear Science and Technology Organisation, New Illawarra Road, Lucas Heights, NSW 2234, Australia. meredith.harrisonbrown@sydney.edu.au.
Ryan J MiddletonAustralian Nuclear Science and Technology Organisation, New Illawarra Road, Lucas Heights, NSW 2234, Australia. rym@ansto.gov.au.
Richard BanatiAustralian Nuclear Science and Technology Organisation, New Illawarra Road, Lucas Heights, NSW 2234, Australia. rib@ansto.gov.au.
Guo-Jun LiuAustralian Nuclear Science and Technology Organisation, New Illawarra Road, Lucas Heights, NSW 2234, Australia. gdl@ansto.gov.au.ORCID 0000-0002-4278-8372

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inducible expression of the mitochondrial translocator protein 18 kDa (TSPO) by activated microglia is a prominent, regular feature of acute and chronic-progressive brain pathology. This expression is also the rationale for the continual development of new TSPO binding molecules for the diagnosis of "neuroinflammation" by molecular imaging. However, there is in the normal brain an ill-defined, low-level constitutive expression of TSPO. Taking advantage of healthy TSPO knockout mouse brain tissue to validate TSPO antibody specificity, this study uses immunohistochemistry to determine the regional distribution and cellular sources of TSPO in the normal mouse brain. Fluorescence microscopy revealed punctate TSPO immunostaining in vascular endothelial cells throughout the brain. In the olfactory nerve layers and glomeruli of the olfactory bulb, choroid plexus and ependymal layers, we confirm constitutive TSPO expression levels similar to peripheral organs, while some low TSPO expression is present in regions of known neurogenesis, as well as cerebellar Purkinje cells. The distributed-sparse expression of TSPO in endothelial mitochondria throughout the normal brain can be expected to give rise to a low baseline signal in TSPO molecular imaging studies. Finally, our study emphasises the need for valid and methodologically robust verification of the selectivity of TSPO ligands through the use of TSPO knockout tissues.

Indexed as

Brain ChemistryAnimalsBrainImmunohistochemistryMice, Inbred C57BLMice, KnockoutMicroscopy, FluorescencePositron-Emission TomographyReceptors, GABABzrp protein, mouseReceptors, GABAimmunohistochemistrymitochondrianeuroinflammationpositron emission tomographytranslocator protein

Identifiers

PMID30208620
PMCPMC6163555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.